kingrichards
02-08-2010, 07:27 AM
Here is Stockpalooza's Pre Market Alert!! MLDH!!
MIT is continually investing in the research and development of its products by consulting and collaborating in clinical tests with renowned pharmaceutical companies, universities and physicians in veterinary and human medicine
Medical International Technologies (MIT Canada) Inc., headquartered in Montreal, specializes in the development, production, marketing, and sale of needle-free jet injectors both for humans and animals, for individual and mass vaccinations. MIT produces many different, professional, state-of-the-art needle-free injection systems that eradicate almost all of the problems associated with today’s needle delivery systems. MIT injectors are fully protected and have already received European Union certification (CE Marking), Health Canada certification (Canadian Medical Device Conformity Assessment System), and full International Organization for Standardization certification (ISO 9001 & 13485 certification) for human use. MIT’s devices are currently sold and in use in multiple countries, including but not limited to the USA, Canada, Australia, England, Holland, China, Malaysia, and Singapore.
MIT is continually investing in the research and development of its products by consulting and collaborating in clinical tests with renowned pharmaceutical companies, universities and physicians in veterinary and human medicine
Medical International Technologies (MIT Canada) Inc., headquartered in Montreal, specializes in the development, production, marketing, and sale of needle-free jet injectors both for humans and animals, for individual and mass vaccinations. MIT produces many different, professional, state-of-the-art needle-free injection systems that eradicate almost all of the problems associated with today’s needle delivery systems. MIT injectors are fully protected and have already received European Union certification (CE Marking), Health Canada certification (Canadian Medical Device Conformity Assessment System), and full International Organization for Standardization certification (ISO 9001 & 13485 certification) for human use. MIT’s devices are currently sold and in use in multiple countries, including but not limited to the USA, Canada, Australia, England, Holland, China, Malaysia, and Singapore.
MIT is continually investing in the research and development of its products by consulting and collaborating in clinical tests with renowned pharmaceutical companies, universities and physicians in veterinary and human medicine
Medical International Technologies (MIT Canada) Inc., headquartered in Montreal, specializes in the development, production, marketing, and sale of needle-free jet injectors both for humans and animals, for individual and mass vaccinations. MIT produces many different, professional, state-of-the-art needle-free injection systems that eradicate almost all of the problems associated with today’s needle delivery systems. MIT injectors are fully protected and have already received European Union certification (CE Marking), Health Canada certification (Canadian Medical Device Conformity Assessment System), and full International Organization for Standardization certification (ISO 9001 & 13485 certification) for human use. MIT’s devices are currently sold and in use in multiple countries, including but not limited to the USA, Canada, Australia, England, Holland, China, Malaysia, and Singapore.
MDLH
MDLH Medical Intl Technology Inc (OTC BB) Delayed quote data 2/5/2010
hide quote detailed quote options chain chart help
Last:
0.40 Change:
+ 0.06Open:
0.34High:
0.40Low:
0.34Volume:
54,800
Percent Change:
+ 17.65%Yield:
n/aP/E Ratio:
n/a52 Week Range:
0.01 to 0.40
Their mission is to provide the veterinary and human medical communities with state of the art delivery systems that ensure comfort to the patient, safety to the environment, ease of use, and affordability to the user.
Their Vision is… a world without needles.
Please do your own research,
Thanks, from KIng Richards
www.stockpalooza.com (http://www.stockpalooza.com)
__________________________________________________ __________________________________
[**(DISCLAIMER)**Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.]The disclaimer is to be read and fully understood before using our site or joining our email list.PLEASE NOTE WELL: Stockpalooza.com and/or its affiliates are not registered as Investment Advisors in any jurisdiction whatsoever. Release of Liability: Through use of Stockpalooza.com email newsletter and website you agree to hold Stockpalooza.com, its operators, owners, and employees harmless and completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. Stockpalooza.com and/or its affiliates may from time to time have positions in the securities mentioned herein, may increase or decrease such positions without notice, and may profit from such transactions. Any opinions expressed are subject to change without notice. Stockpalooza.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice.Stockpalooza was compensated by a third party Consultants/or third party shareholder $30,000 (cash) U.S. Dollars for a 3 days campaign.
MIT is continually investing in the research and development of its products by consulting and collaborating in clinical tests with renowned pharmaceutical companies, universities and physicians in veterinary and human medicine
Medical International Technologies (MIT Canada) Inc., headquartered in Montreal, specializes in the development, production, marketing, and sale of needle-free jet injectors both for humans and animals, for individual and mass vaccinations. MIT produces many different, professional, state-of-the-art needle-free injection systems that eradicate almost all of the problems associated with today’s needle delivery systems. MIT injectors are fully protected and have already received European Union certification (CE Marking), Health Canada certification (Canadian Medical Device Conformity Assessment System), and full International Organization for Standardization certification (ISO 9001 & 13485 certification) for human use. MIT’s devices are currently sold and in use in multiple countries, including but not limited to the USA, Canada, Australia, England, Holland, China, Malaysia, and Singapore.
MIT is continually investing in the research and development of its products by consulting and collaborating in clinical tests with renowned pharmaceutical companies, universities and physicians in veterinary and human medicine
Medical International Technologies (MIT Canada) Inc., headquartered in Montreal, specializes in the development, production, marketing, and sale of needle-free jet injectors both for humans and animals, for individual and mass vaccinations. MIT produces many different, professional, state-of-the-art needle-free injection systems that eradicate almost all of the problems associated with today’s needle delivery systems. MIT injectors are fully protected and have already received European Union certification (CE Marking), Health Canada certification (Canadian Medical Device Conformity Assessment System), and full International Organization for Standardization certification (ISO 9001 & 13485 certification) for human use. MIT’s devices are currently sold and in use in multiple countries, including but not limited to the USA, Canada, Australia, England, Holland, China, Malaysia, and Singapore.
MIT is continually investing in the research and development of its products by consulting and collaborating in clinical tests with renowned pharmaceutical companies, universities and physicians in veterinary and human medicine
Medical International Technologies (MIT Canada) Inc., headquartered in Montreal, specializes in the development, production, marketing, and sale of needle-free jet injectors both for humans and animals, for individual and mass vaccinations. MIT produces many different, professional, state-of-the-art needle-free injection systems that eradicate almost all of the problems associated with today’s needle delivery systems. MIT injectors are fully protected and have already received European Union certification (CE Marking), Health Canada certification (Canadian Medical Device Conformity Assessment System), and full International Organization for Standardization certification (ISO 9001 & 13485 certification) for human use. MIT’s devices are currently sold and in use in multiple countries, including but not limited to the USA, Canada, Australia, England, Holland, China, Malaysia, and Singapore.
MDLH
MDLH Medical Intl Technology Inc (OTC BB) Delayed quote data 2/5/2010
hide quote detailed quote options chain chart help
Last:
0.40 Change:
+ 0.06Open:
0.34High:
0.40Low:
0.34Volume:
54,800
Percent Change:
+ 17.65%Yield:
n/aP/E Ratio:
n/a52 Week Range:
0.01 to 0.40
Their mission is to provide the veterinary and human medical communities with state of the art delivery systems that ensure comfort to the patient, safety to the environment, ease of use, and affordability to the user.
Their Vision is… a world without needles.
Please do your own research,
Thanks, from KIng Richards
www.stockpalooza.com (http://www.stockpalooza.com)
__________________________________________________ __________________________________
[**(DISCLAIMER)**Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.]The disclaimer is to be read and fully understood before using our site or joining our email list.PLEASE NOTE WELL: Stockpalooza.com and/or its affiliates are not registered as Investment Advisors in any jurisdiction whatsoever. Release of Liability: Through use of Stockpalooza.com email newsletter and website you agree to hold Stockpalooza.com, its operators, owners, and employees harmless and completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. Stockpalooza.com and/or its affiliates may from time to time have positions in the securities mentioned herein, may increase or decrease such positions without notice, and may profit from such transactions. Any opinions expressed are subject to change without notice. Stockpalooza.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice.Stockpalooza was compensated by a third party Consultants/or third party shareholder $30,000 (cash) U.S. Dollars for a 3 days campaign.